Pfizer's Paxlovid antiviral drug lowered risk of long COVID symptoms in study

Retrieved on: 2022-11-07 13:10:28

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's Paxlovid antiviral drug lowered risk of long COVID symptoms in study. View article details on hiswai:

Excerpt

Taking Pfizer's Paxlovid antiviral drug within five days of testing positive for a SARS-CoV-2 infection was linked to a 26% lower risk of ...

Article found on: www.stripes.com